News

Pharmaceutical giant Eli Lilly alleges the companies are selling illegal off-brand versions of its best-selling diabetes and ...
Ozempic, the brand name for semaglutide, was approved by the U.S. Food and Drug Administration (FDA) in 2017 to help adults manage type 2 diabetes. It is administered through a weekly injection ...
LIKE MANY OTHER PROVIDERS, NP TO-GO OFFERED THEIR PATIENTS COPYCAT VERSIONS OF THE SEMAGLUTIDE FROM COMPOUNDING PHARMACIES, BUT THAT HAS COME TO A HALT AFTER THE FDA DECLARED THERE WAS NO LONGER A ...
Half of the participants got a weekly shot of semaglutide, the drug in Ozempic and Wegovy, while the other half got a placebo injection. The participants were followed for a total of six months.
In this exclusive interview, Business Today speaks with Vikrant Shrotriya, Managing Director of Novo Nordisk India, about the significance of semaglutide (the active ingredient in Wegovy), its ...
Compounded semaglutide and Ozempic are different products. While both may be used in people with type 2 diabetes, Ozempic is approved by the FDA, but compounded semaglutide is not. Compounded ...
Semaglutide 2.4 mg could prevent nearly 2 million major cardiac events and over 1 million deaths in eligible patients. Uptake of semaglutide remains low due to cost, supply issues, and payer ...
The most popular GLP-1 agent today is semaglutide, the active ingredient in type 2 diabetes medication Ozempic and the higher-dose obesity drug Wegovy. Semaglutide and newer GLP-1 drugs help ...
One such breakthrough comes from PharmaZee, a leading provider of GLP-1 medication, particularly Semaglutide. PharmaZee’s weight loss program has gained significant attention for its use of GLP ...
As per a media report in March 2024, Medicare may extend coverage for Novo Nordisk’s weight-loss drug Wegovy (semaglutide) to certain members with a history of heart disease. The CMS revealed ...
A Connecticut surgical nurse has admitted to stealing hydromorphone and fentanyl vials for personal use and refilling them with saline or water to distribute to patients, federal officials said.